Literature DB >> 8928871

Characterization of a stimulatory adenosine A2a receptor in adult rat ventricular myocyte.

H Xu1, B Stein, B Liang.   

Abstract

The expression and function of stimulatory adenosine A2 receptor on the cardiac myocyte is not well defined. The objective of the present study is to characterize the A2a receptor in adult rat cardiac ventricular myocytes. After selection of an optimal lot of collagenase for myocyte isolation and for consistent measurement of adenosine-mediated responses, the A1-receptor pathway was inactivated by pertussis toxin and by the A1-selective antagonist 1,3-dipropyl-8-cyclopentylxanthine. Effects of the adenosine agonist and antagonist or cardiac myocyte contractile amplitude and on adenosine 3',5'-cyclic monophosphate (cAMP) levels were determined. The A2a-receptor-selective agonist 2-[p-(2-carboxyethyl)phenylethylamino]-5'-N-ethylcarboxamidoade nos ine (CGS-21680) caused a pronounced stimulation of myocyte contractile amplitude and an increase in the cAMP level, as did the nonselective agonists 5'-(N-ethylcarboxamido) adenosine (NECA) and adenosine. The A2a-receptor-selective antagonist 8-(3-chlorostyryl)caffeine blocked the NECA- and adenosine-induced positive inotropic response. Probing of myocyte RNA with a rat A2a-receptor cDNA demonstrated a 2.6-kb mRNA, corresponding to that encoding the A2a receptor. Together, data from contractile, cAMP, and RNA studies indicate that A2a receptors are expressed and are functionally coupled to stimulation of cAMP accumulation and cardiac contractility in adult rat ventricular myocytes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8928871     DOI: 10.1152/ajpheart.1996.270.5.H1655

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Cardiac receptor physiology and its application to clinical imaging: present and future.

Authors:  H Tseng; J M Link; J R Stratton; J H Caldwell
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

2.  A(2b) adenosine receptors can change their spots.

Authors:  Michael V Cohen; Xiulan Yang; James M Downey
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

3.  Differential effects of adenosine A2a and A2b receptors on cardiac contractility.

Authors:  P Charukeshi Chandrasekera; Victoria J McIntosh; Frank X Cao; Robert D Lasley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-08       Impact factor: 4.733

Review 4.  Adenosine receptors and reperfusion injury of the heart.

Authors:  John P Headrick; Robert D Lasley
Journal:  Handb Exp Pharmacol       Date:  2009

5.  Functional studies in atrium overexpressing A1-adenosine receptors.

Authors:  J Neumann; U Vahlensieck; P Boknik; B Linck; H Lüss; F U Müller; G P Matherne; W Schmitz
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  Contractile effects of adenosine, coronary flow and perfusion pressure in murine myocardium.

Authors:  Laura Willems; John P Headrick
Journal:  Pflugers Arch       Date:  2006-10-28       Impact factor: 3.657

7.  Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat hearts.

Authors:  Jinkun Xi; Rachel McIntosh; Xiangjun Shen; SungRyul Lee; Guillaume Chanoit; Hugh Criswell; David A Zvara; Zhelong Xu
Journal:  J Mol Cell Cardiol       Date:  2009-08-18       Impact factor: 5.000

Review 8.  Modulation of cardiac remodeling by adenosine: in vitro and in vivo effects.

Authors:  Francisco Villarreal; Scott Zimmermann; Lala Makhsudova; Annika C Montag; Mark D Erion; David A Bullough; Bruce R Ito
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

9.  Characterization of ERK1/2 signalling pathways induced by adenosine receptor subtypes in newborn rat cardiomyocytes.

Authors:  Renée Germack; John M Dickenson
Journal:  Br J Pharmacol       Date:  2004-01       Impact factor: 8.739

10.  A positive inotropic effect of adenosine in cardiac preparations of right atria from diseased human hearts.

Authors:  Ulrich Gergs; Peter Boknik; Wilhelm Schmitz; Andreas Simm; Rolf-Edgar Silber; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-11-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.